Statins and the COVID-19 main protease: in silico evidence on direct interaction.
Conclusions: These results indicate, based upon the binding energy of pitavastatin, rosuvastatin, lovastatin, and fluvastatin, that statins could be efficient SARS-CoV-2 Mpro inhibitors. This is supported by the fact that the effects of some statins, especially pitavastatin, have a binding energy that is even greater than that of protease or polymerase inhibitors. However, further research is necessary to investigate their potential use as drugs for COVID-19.
PMID: 32399094 [PubMed]
Source: Archives of Medical Science - Category: General Medicine Tags: Arch Med Sci Source Type: research
More News: Atorvastatin Calcium | Biomedical Science | Cholesterol | Coronavirus | COVID-19 | Crestor | Fluvastatin | General Medicine | Lipitor | Lovastatin | Pravastatin | Rosuvastatin | SARS | Science | Simvastatin | Statin Therapy | Study | Zivast | Zocor